Archean Chemical
Archean Chemical Q1 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Q1 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Overall Revenue Growth:** Q1 FY26 saw a 30% YoY revenue growth; steady growth expected ahead. Q1 FY26 standalone EBITDA grew 13% YoY to INR 958 million with 33% margin; consolidated net profit stood at INR 401 million.
From Archean Chemical's Q1 FY26 earnings-call transcript · updated 26 Aug 2026.
Revenue & Sales Performance
- **Overall Revenue Growth:** Q1 FY26 saw a 30% YoY revenue growth; steady growth expected ahead.
- **Bromine Volumes:** Current run rate ~4,000 tons, aiming for 22,000 to 25,000 tons FY26 with 20-25% growth guidance; volume ramp-up expected over next quarters.
- **Industrial Salt:** Maintained ~1.1 million tons sales volume with stable long-term contracts; potential for incremental volume growth.
- **Sulphate of Potash (SOP):** Pilot trials successful; plant scale trials underway; meaningful contribution anticipated in H2 FY26.
- **Bromine Derivatives:** Operating at 30-40% capacity; expected to cross 50% utilization by FY end; introduction of new products planned.
- **Oren Hydrocarbon Business:** Targeting INR 150 crores revenue in FY26; ramp-up expected from Q3 post product certifications.
- **Subsidiaries:** Derivative businesses expected to move towards PAT positivity in FY26 as ramp-up continues.
- **Market Outlook:** Long-term contracts, strong customer relationships, and improving demand supporting growth confidence.
Profitability & Margins
See what Archean Chemical said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Land acquisition completed for Semiconductor project in Odisha; groundwork expected to commence post-monsoon 2025.
- Tendered RFQs for project management office for Semiconductor initiative last month.
- Invested in Offgrid Energy Labs (zinc-bromide battery innovator) with 18.14% stake acquired; remaining commitment to be fulfilled over coming quarters.
- Offgrid finalized pilot site and vendor selection for pilot plant in the U.K.
- Upon successful pilot, plan to scale up to gigafactory within 18 to 24 months.
- Focus on strategic investments in high-potential sectors: Bromine Derivatives, Semiconductors, and Energy Storage.
- Emphasis on disciplined capital allocation backed by a robust balance sheet and net debt free status.
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Archean Chemical said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The order book for Bromine and related products is reported to be full.
- The company mentioned that historically, whatever production capacity is available, they are able to sell fully.
- Strong demand visibility exists for Industrial Salt, supported by long-term contracts with end customers across Asia.
- For derivatives and newer businesses, the company is focused on product qualification and gaining approvals before commercial scale-up.
- Demand for Bromine and salt remains robust, with customers placing orders consistently and trust in supply continuity.
- Bromine Derivatives segment is gradually ramping up utilization and adding new products to the portfolio, indicating a growing order pipeline.
- There is no specific numeric value disclosed for the pending orders or orderbook in the call.
Archean Chemical — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹301 Cr, net profit ₹12 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Archean Chemical's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q4 FY25 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q2 FY26 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
Others in Chemicals & Petrochemicals this season
- PCBL Chemical (Q1 FY26)
Plant closures in Europe/North America may open export opportunities, boosting international sales beyond the current 41% mix. Key concall takeaways from PCBL…
- Rain Industries (Q1 FY26)
Carbon segment capacity utilization is around 68%, with efforts to increase utilization underway. Key concall takeaways from Rain Industries's Q1 FY26 earnings…
- Styrenix Perfor. (Q1 FY26)
Thailand plant utilization is at 50-55% with potential to increase revenue by 70-80% by ramping up capacity and improving product mix. Key concall takeaways…
- Aether Industri. (Q1 FY26)
Sales revenue grew 35% YoY in Q1 FY '26, indicating strong growth momentum. Key concall takeaways from Aether Industries Ltd's Q1 FY26 earnings call — and how…
Frequently Asked Questions
What were Archean Chemical Q1 FY26 results?
Overall Revenue Growth:** Q1 FY26 saw a 30% YoY revenue growth; steady growth expected ahead. Q1 FY26 standalone EBITDA grew 13% YoY to INR 958 million with 33% margin; consolidated net profit stood at INR 401 million.
What is Archean Chemical share price analysis?
Archean Chemical currently shows a neutral. The stock trades at a P/E of 63.5 with a market cap of ₹6,146 Cr. Investors should review the full earnings analysis for detailed insights.
Is Archean Chemical planning capital expenditure?
Land acquisition completed for Semiconductor project in Odisha; groundwork expected to commence post-monsoon 2025.
Keep Archean Chemical on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.